bioRxivCancer Biology
Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.
M. S. Sumanth, Y. Liu, J. Wu, L. Fechter, K. Murugesan, H. Maecker, J. Gotlib, J. Zehnder, R. Paulmurugan, A. Krishnan
Abstract
Impaired protein homeostasis, though well established in age-related disorders, has been linked in recent research with the pathogenesis of myeloproliferative neoplasms (MPNs). As yet, however, little is known about MPN-specific modulators of proteostasis, thus impeding our ability for increased mechanistic understanding and discovery of additional therapeutic targets. Loss of proteostasis, in itself, is traced to dysregulated mechanisms in protein folding and intracellular calcium signaling at the endoplasmic reticulum (ER). Here, using ex vivo and in vitro systems (including CD34+ cultures from patient bone marrow, and healthy cord/peripheral blood specimens), we extend our prior data from MPN patient platelet RNA sequencing, and discover select proteostasis-associated markers at RNA and/or protein levels in each of platelets, parent megakaryocytes, and whole blood specimens. Importantly, we identify a novel role in MPNs for enkurin (ENKUR), a calcium mediator protein, implicated originally only in spermatogenesis. Our data reveal consistent ENKUR downregulation at both RNA and protein levels across MPN patient specimens and experimental models, with a concomitant upregulation of a cell cycle marker, CDC20. Silencing of ENKUR by shRNA in CD34+ derived megakaryocytes further confirm this association with CDC20 at both RNA and protein levels; and indicate a likely role for the PI3K/Akt pathway. The inverse association of ENKUR and CDC20 expression was further confirmed upon treatment with thapsigargin (an agent that causes protein misfolding in the ER by selective loss of calcium) in both megakaryocyte and platelet fractions at RNA and protein levels. Together, our work sheds light on enkurin as a novel marker of MPN pathogenesis beyond the genetic alterations; and indicates further mechanistic investigation into a role for dysregulated calcium homeostasis, and ER and protein folding stress in MPN transformation. VISUAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=197 HEIGHT=200 SRC="FIGDIR/small/523111v2_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@80834corg.highwire.dtl.DTLVardef@12c033forg.highwire.dtl.DTLVardef@8948c8org.highwire.dtl.DTLVardef@1096184_HPS_FORMAT_FIGEXP M_FIG C_FIG Key PointsO_LIEnkurin, a calcium adaptor protein, is identified as a novel marker of pathogenesis in MPNs. C_LIO_LIMPN megakaryocyte and platelet expression of enkurin at RNA and protein levels is inversely associated with a cell differentiation cycle gene, CDC20. C_LIO_LILikely role for dysregulated calcium homeostasis, and ER and protein folding stress in MPN transformation. C_LI
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms
S. Kelliher, S. Gamba, … A. Krishnan·bioRxiv·Oct 23, 2023
- Megakaryocytic proteomic signatures define myeloproliferative neoplasms
Indu Raman, Cavan Bennett, … Sukhdeep Spall·bioRxiv·Nov 2, 2026
- Lysosomal Degradation Pathways Target Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms
A. Kaur, A. Venkatesan, … M. Raghavan·bioRxiv·Jul 12, 2023
- Plasma proteome screen of individuals with elevated blood counts to identify diagnostic signatures and biomarkers inherent to patients with myeloproliferative neoplasms
Xiangfu Zhong, Ingrid E. J. Lundahl, … Johanna S. Ungerstedt·bioRxiv·Aug 4, 2026
- The Immune-Modulatory Function of Megakaryocytes in the Hematopoietic Niche of Myeloproliferative Neoplasms
Sandy Lee, Xiaoxi Yang, … Huichun Zhan·bioRxiv·Apr 1, 2025
- NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms
R.-M. Koerber, C. Krollmann, … L. L. Teichmann·bioRxiv·Mar 9, 2024